ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,244Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 5176

$1.42M Total Retail Price of All Prescriptions

Rank: 120 out of 5176

731 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 731 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 16,572 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,503 1,369 1 1
AMLODIPINE BESYLATE 931 872 2 2
LEVOTHYROXINE SODIUM 669 641 3 4
OMEPRAZOLE 573 499 4 3
METFORMIN HCL 517 476 5 7
DIOVAN 412 379 6 19
ATENOLOL 376 338 7 12
CRESTOR 370 340 8 15
LOSARTAN POTASSIUM 358 351 9 14
FUROSEMIDE 323 307 10 8
ZOLPIDEM TARTRATE 315 287 11 17
FENOFIBRATE 290 270 12 102
HYDROCHLOROTHIAZIDE 272 249 13 10
ATORVASTATIN CALCIUM 270 240 14 9
NAPROXEN 260 251 15 95
FOSINOPRIL SODIUM 255 243 16 105
METOPROLOL SUCCINATE 244 222 17 11
ACTOS 241 226 18 85
DIOVAN HCT 237 209 19 39
LISINOPRIL 233 197 20 5
LOSARTAN-HYDROCHLOROTHIAZIDE 231 201 21 35
NEXIUM 216 204 22 16
ALENDRONATE SODIUM 205 197 23 18
MECLIZINE HCL 193 186 24 81
JANUVIA 192 176 25 25
TAMSULOSIN HCL 174 165 26 20
NIFEDIPINE ER 168 168 27 48
SINGULAIR 166 144 28 62
JANUMET 153 127 29 77
CARVEDILOL 147 140 30 24
GLIMEPIRIDE 144 126 31 37
LOVAZA 139 120 32 43
ADVAIR DISKUS 125 114 33 32
CLOPIDOGREL 125 105 33 26
EXELON 115 113 35 162
TRAMADOL HCL 113 95 36 40
EVISTA 112 108 37 65
SERTRALINE HCL 112 87 37 30
MELOXICAM 107 107 39 53
ZETIA 106 99 40 68
PIOGLITAZONE HCL 106 106 R 40 237
METOPROLOL TARTRATE 105 86 42 6
ONGLYZA 100 95 43 153
PLAVIX 99 87 44 29
ATELVIA 99 99 44 146
LOVASTATIN 99 95 44 46
LIPITOR 98 83 47 51
DONEPEZIL HCL 91 85 48 28
NIASPAN 90 71 49 175
BENICAR 88 88 50 100
IBUPROFEN 88 58 50 72
CELEBREX 86 83 52 80
METFORMIN HCL ER 83 72 53 57
VYTORIN 83 73 53 152
ACTONEL 81 70 55 134
VOLTAREN 81 68 55 97
LYRICA 80 70 57 133
CLOTRIMAZOLE-BETAMETHASONE 77 65 58 94
LANTUS SOLOSTAR 75 46 59 70
DESOXIMETASONE 75 71 59 278
AMOX TR-POTASSIUM CLAVULANATE 75 66 59 141
AMLODIPINE BESYLATE-BENAZEPRIL 72 63 62 55
NAMENDA 71 65 63 47
RAMIPRIL 70 70 64 50
QUINAPRIL HCL 68 64 65 82
EXFORGE 67 63 66 126
ENALAPRIL MALEATE 66 56 67 22
RANITIDINE HCL 63 61 68 36
METOCLOPRAMIDE HCL 61 60 69 176
CLONIDINE HCL 61 60 69 79
MONTELUKAST SODIUM 60 55 71 123
SPIRIVA 60 60 71 54
MICARDIS HCT 57 57 73 180
DILTIAZEM 24HR CD 56 43 74 119
BYSTOLIC 56 50 74 96
EXFORGE HCT 55 55 76 266
MICARDIS 53 53 77 154
PRAVASTATIN SODIUM 51 51 78 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.